Vyome Holdings, Inc.(HIND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HIND Vyome Holdings, Inc.

交易中 02-03 14:20:26 EST

2.03

-0.17

-7.73%

最高2.33	最低2.01	成交量40.52万
今开2.17	昨收2.20	日振幅14.54%
总市值1,146万	流通市值629.12万	总股本564.45万
成交额87.57万	换手率13.07%	流通股本309.91万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HIND","market":"US","secType":"STK","nameCN":"Vyome Holdings, Inc.","latestPrice":2.03,"timestamp":1770146391895,"preClose":2.2,"halted":0,"volume":405160,"delay":0,"changeRate":-0.07727272727272744,"floatShares":3099100,"shares":5644494,"eps":-183.1419,"marketStatus":"交易中","change":-0.17,"latestTime":"02-03 14:20:26 EST","open":2.17,"high":2.33,"low":2.0101,"amount":875741.630876,"amplitude":0.145409,"askPrice":2.07,"askSize":100,"bidPrice":2.02,"bidSize":120,"shortable":3,"etf":0,"ttmEps":-183.1419,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770152400000},"marketStatusCode":2,"adr":0,"listingDate":1475726400000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.17,"preClose":2.2,"latestTime":"09:29 EST","volume":61632,"amount":132161.8919616,"timestamp":1770128965940,"change":-0.03,"changeRate":-0.013636,"amplitude":0.033455},"postHourTrading":{"tag":"盘后","latestPrice":2.1114,"preClose":2.2,"latestTime":"19:59 EST","volume":18963,"amount":40778.1664,"timestamp":1770080358742,"change":-0.0886,"changeRate":-0.040273,"amplitude":0.040909},"volumeRatio":0.057059},"requestUrl":"/m/hq/s/HIND","defaultTab":"news","newsList":[{"id":"1186890961","title":"独立分析师评估：Vyome旗下Vt-1953若三期研究成功，估值将达10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186890961","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186890961?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:02","pubTimestamp":1769518963,"startTime":"0","endTime":"0","summary":"据独立分析师最新评估，若Vyome Holdings, Inc.研发的Vt-1953药物能顺利通过三期临床试验，其市场价值有望突破10亿美元大关。这一估值凸显了该创新疗法在医疗领域的巨大潜力，也为投资者提供了明确的价值参考。随着三期研究进入关键阶段，市场对Vt-1953的未来表现持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND","BK4007"],"gpt_icon":0},{"id":"2605709334","title":"Vyome Holdings, Inc.盘中异动 早盘大幅上涨5.97%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605709334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605709334?lang=zh_cn&edition=full","pubTime":"2026-01-22 23:27","pubTimestamp":1769095657,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日23时27分，Vyome Holdings, Inc.股票出现波动，股价大幅上涨5.97%。截至发稿，该股报2.84美元/股，成交量6434股，换手率0.11%，振幅4.85%。Vyome Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Io Biotech, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为11727.51%、370.41%、288.13%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为131.00%、69.40%、36.70%。Vyome Holdings, Inc.公司简介：Vyome Holdings Inc是一家研发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012223273897a2fc55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012223273897a2fc55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HIND","BK4007","BK4082"],"gpt_icon":0},{"id":"2603951817","title":"Vyome Holdings, Inc.盘中异动 早盘急速拉升9.27%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603951817?lang=zh_cn&edition=full","pubTime":"2026-01-15 22:33","pubTimestamp":1768487619,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日22时33分，Vyome Holdings, Inc.股票出现波动，股价急速上涨9.27%。截至发稿，该股报3.30美元/股，成交量629股，换手率0.01%，振幅6.62%。Vyome Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Cns Pharmaceuticals, Inc.、Ocular Therapeutix, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Gt Biopharma, Inc.、Applied Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为48.80%、42.49%、15.18%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Metavia Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为15.65%、12.18%、11.84%。Vyome Holdings, Inc.公司简介：Vyome Holdings Inc是一家研发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223339a4c81a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115223339a4c81a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","HIND","BK4007"],"gpt_icon":0},{"id":"1137069214","title":"Vyome控股子公司LIVECHAIN INC.收购MIT孵化公司Humanyze的高级担保票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1137069214","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137069214?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:03","pubTimestamp":1766408623,"startTime":"0","endTime":"0","summary":"Vyome控股子公司LIVECHAIN INC.将收购MIT孵化公司Humanyze的高级担保票据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4007","LICH","HIND","BK4023"],"gpt_icon":0},{"id":"2592197015","title":"Vyome Holdings, Inc.盘中异动 下午盘快速下挫6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592197015?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:38","pubTimestamp":1766173114,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日03时38分，Vyome Holdings, Inc.股票出现波动，股价快速跳水6.11%。截至发稿，该股报3.64美元/股，成交量1.9053万股，换手率0.34%，振幅8.19%。Vyome Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Novabay Pharmaceuticals, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、爱美医疗涨幅较大，Psyence Biomedical Ltd.、In8Bio, Inc.、Neuraxis, Inc.较为活跃，换手率分别为1793.90%、224.50%、137.82%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Geovax Labs, Inc.，振幅分别为92.37%、59.87%、57.35%。Vyome Holdings, Inc.公司简介：Vyome Holdings Inc是一家研发公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220033835953b7696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220033835953b7696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HIND","BK4082","BK4007"],"gpt_icon":0},{"id":"1116502243","title":"Vyome Holdings, Inc. - 将与FDA合作设计并启动2026年重要的三期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1116502243","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116502243?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:13","pubTimestamp":1765199623,"startTime":"0","endTime":"0","summary":"Vyome Holdings, Inc. - 将与FDA合作设计并启动2026年重要的三期临床研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIND","BK4007","BK4082"],"gpt_icon":0},{"id":"1170919255","title":"Vyome公布Vt-1953最终二期试验积极结果；计划推进至FDA批准的关键研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1170919255","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170919255?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:12","pubTimestamp":1765199558,"startTime":"0","endTime":"0","summary":"Vyome公布Vt-1953最终二期试验积极结果；计划推进至FDA批准的关键研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND","BK4007"],"gpt_icon":0},{"id":"1175842988","title":"Vyome Holdings Inc：VT-1953治疗恶性真菌创面的二期研究获得积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1175842988","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175842988?lang=zh_cn&edition=full","pubTime":"2025-09-04 20:32","pubTimestamp":1756989144,"startTime":"0","endTime":"0","summary":"Vyome Holdings Inc：VT-1953治疗恶性真菌创面的二期研究获得积极中期数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","HIND"],"gpt_icon":0},{"id":"2558661256","title":"Reshape Lifesciences, Inc.盘中异动 股价大跌6.16%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661256?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:31","pubTimestamp":1754919077,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时31分，Reshape Lifesciences, Inc.股票出现波动，股价大幅跳水6.16%。截至发稿，该股报2.10美元/股，成交量3.1652万股，换手率1.33%，振幅0.80%。Reshape Lifesciences, Inc.股票所在的医疗器械行业中，整体跌幅为0.26%。Reshape Lifesciences, Inc.公司简介：Reshape Lifesciences Inc 是一家专注于治疗肥胖症和代谢性疾病的医疗器械公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213117a6dfb7ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213117a6dfb7ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HIND","RSLS","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.reshapelifesciences.com","stockEarnings":[{"period":"1week","weight":-0.2926},{"period":"1month","weight":-0.3803},{"period":"3month","weight":-0.6434},{"period":"6month","weight":-0.7868},{"period":"1year","weight":-0.9942},{"period":"ytd","weight":-0.3605}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vyome Holdings, Inc.于2008年1月2日根据特拉华州法律注册成立。ReShape Lifesciences Inc.与Vyome Therapeutics，Inc.已于2025年8月14日完成合并。合并完成后，更名为Vyome Holdings，Inc.。该公司主要是一家临床阶段的制药公司，拥有多项资产，专注于免疫和炎症性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.065188},{"month":2,"riseRate":0.1,"avgChangeRate":-0.188622},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.191303},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.109458},{"month":5,"riseRate":0.666667,"avgChangeRate":0.233167},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.317083},{"month":7,"riseRate":0.111111,"avgChangeRate":-0.116956},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.042502},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.213103},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.062941},{"month":11,"riseRate":0.2,"avgChangeRate":-0.120626},{"month":12,"riseRate":0.4,"avgChangeRate":-0.030035}],"exchange":"NASDAQ","name":"Vyome Holdings, Inc.","nameEN":"Vyome Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vyome Holdings, Inc.(HIND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vyome Holdings, Inc.(HIND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vyome Holdings, Inc.,HIND,Vyome Holdings, Inc.股票,Vyome Holdings, Inc.股票老虎,Vyome Holdings, Inc.股票老虎国际,Vyome Holdings, Inc.行情,Vyome Holdings, Inc.股票行情,Vyome Holdings, Inc.股价,Vyome Holdings, Inc.股市,Vyome Holdings, Inc.股票价格,Vyome Holdings, Inc.股票交易,Vyome Holdings, Inc.股票购买,Vyome Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vyome Holdings, Inc.(HIND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vyome Holdings, Inc.(HIND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}